galactose has been researched along with Hepatitis, Chronic in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (25.00) | 18.7374 |
1990's | 6 (75.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Craske, J; Cuthbert, AC; Haboubi, NY; Longson, M; Perera, PR; Smith, A; Stevens, RF; Warnes, TW; Wensley, RT; Whitwell, HL | 1 |
Bianchi, L; Dällenbach, A; Reichen, J; Renner, EL; Schmid, M; Solioz, M | 1 |
Chang, CL; Hu, OY; Tang, HS | 1 |
Fiume, L; Verme, G | 1 |
Hu, OY; Tang, HS | 1 |
Aebli, N; Reichen, J | 1 |
Kürzl, R | 1 |
Broström, C; Foberg, U; Frydén, A; Glaumann, H; Kågedal, B; Mårtensson, J; Tobiasson, P; Weiland, O | 1 |
1 review(s) available for galactose and Hepatitis, Chronic
Article | Year |
---|---|
Liver targeting of nucleoside analogues coupled to galactosyl terminating macromolecules: a new approach to the treatment of a chronic viral hepatitis.
Topics: Amino Sugars; Animals; Antiviral Agents; Asialoglycoproteins; DNA; Drug Carriers; Galactose; Hepatitis, Chronic; Hepatitis, Viral, Human; Humans; Liver; Lysosomes; Polylysine; Ribavirin; Serum Albumin; Vidarabine Phosphate; Virus Replication | 1997 |
1 trial(s) available for galactose and Hepatitis, Chronic
Article | Year |
---|---|
The influence of chronic lobular hepatitis on pharmacokinetics of cefoperazone--a novel galactose single-point method as a measure of residual liver function.
Topics: Adult; Biomarkers; Blood Proteins; Cefoperazone; Chromatography, High Pressure Liquid; Computer Simulation; Galactose; Hepatitis, Chronic; Humans; Injections, Intravenous; Liver; Liver Function Tests; Male; Middle Aged; Models, Biological; Protein Binding | 1994 |
6 other study(ies) available for galactose and Hepatitis, Chronic
Article | Year |
---|---|
Liver disease in haemophiliacs: an overstated problem?
Topics: Adolescent; Adult; Galactose; Hemophilia A; Hepatitis, Chronic; Humans; Liver; Liver Function Tests; Transaminases | 1983 |
[Does serum HCV-RNA-positive hepatitis C differ from serum HCV-RNA-negative hepatitis C?].
Topics: Adult; Aged; Biopsy, Needle; Breath Tests; Female; Galactose; Hepatitis C; Hepatitis, Chronic; Humans; Liver; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Prognosis; RNA, Viral; Viremia | 1995 |
Assessment of liver function using a novel galactose single point method.
Topics: Adult; Carcinoma, Hepatocellular; Evaluation Studies as Topic; Female; Galactose; Hepatitis, Chronic; Humans; Liver Cirrhosis; Liver Function Tests; Liver Neoplasms; Male; Middle Aged | 1992 |
[The prognostic value of the serial determination of galactose elimination capacity in chronic active hepatitis].
Topics: Adult; Aged; Female; Galactose; Hepatitis, Chronic; Humans; Liver; Liver Function Tests; Male; Middle Aged; Predictive Value of Tests; Prognosis; Retrospective Studies; Sensitivity and Specificity; Survival Analysis | 1991 |
["Prognostic value of serial galactose elimination determination in chronic-active hepatitis" by N. Aebli et al., Schweiz. med. Wschr. 1991; 121: 970-976].
Topics: Galactose; Hepatitis, Chronic; Humans; Predictive Value of Tests; Sensitivity and Specificity | 1991 |
Evaluation of an oral bile acid loading test for assessment of liver function in chronic hepatitis. A comparison with fasting serum bile acids and i.v. galactose elimination test.
Topics: Adult; Aged; Chenodeoxycholic Acid; Cholic Acid; Cholic Acids; Female; Galactose; Hepatitis; Hepatitis, Chronic; Humans; Liver; Liver Function Tests; Male; Middle Aged | 1987 |